AcquisitionsJul 31, 2026, 05:17 PM
Profusa Signs Option to Acquire G3 Vision Labs, Est. $111M Revenue
AI Summary
Profusa, Inc. announced the signing of an Option Agreement to acquire G3 Vision Labs, Inc. and its subsidiaries, which include Med Screen Laboratories, Dominion Diagnostics, and Acutis Diagnostics. G3's estimated 2025 net revenues are approximately $111 million. The option's exercise is subject to several conditions, including Profusa securing at least $30 million in financing and G3's indebtedness being refinanced or satisfied. As consideration for the option, Profusa issued 201,120 common shares and 52,903.566 shares of a new series of non-voting convertible preferred stock to G3 stockholders.
Key Highlights
- Signed Option Agreement to acquire G3 Vision Labs and its subsidiaries.
- G3 Vision Labs' estimated 2025 Net Revenues: ~$111 million.
- Consideration for option: 201,120 Profusa common shares.
- Consideration for option: 52,903.566 shares of newly-designated preferred stock.
- Exercise conditions include $30 million in financing and G3 debt refinancing.
- Additional 53,918.113 preferred shares if the option is exercised.
- Each preferred share is convertible into 1,000 Profusa common shares.
Price Impact
More from PFSA